Circulating Prostate Cancer Progenitor Cell Assay Development

Award Information

Agency: Department of Defense	Branch: Army	Award ID:	Program Year/Program: 2011 / STTR
Agency Tracking Number: A2-4144	Solicitation Year: 2008	Solicitation Topic Code: A08-T041	Solicitation Number: 2008.A

Small Business Information: ANDROBIOSYS, INC.
Elm and Carlton Streets BUFFALO, NY 14263-
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 2: Fiscal Year: 2011

Title: Circulating Prostate Cancer Progenitor Cell Assay Development

Agency / Branch: DOD / ARMY

Contract: W81XWH-08-C-0099

Award Amount: $747,553.00

Abstract:
The technical objectives of this Phase II project are to identify unique biomarkers and produce molecular, antibody and peptide reagents that are specific for human prostate cancer progenitor stem cells. We propose to utilize the information from the Phase I award and subsequent research to develop assay reagents that would be used to develop a blood-based assay specific for circulating prostate cancer stem cells. This assay should prove to be an informative prognostic tool for predicting aggressiveness and metastatic potential of prostate cancer.

Principal Investigator:
Michael G. Zwick
CEO
(716) 860-7920
mzwick@androbiosys.com

Business Contact:
Michael G. Zwick
CEO
(716) 860-7920
mzwick@androbiosys.com

Small Business Information at Submission:

AndroBioSys, Inc.
73 High Street Buffalo, NY 14203-1149

EIN/Tax ID: 202315778

DUNS: N/A

Number of Employees:

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: Yes

Research Institution Information:

Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo, NY 14263-

Contact: John T. Blandino

Contact Phone: (716) 845-2312